Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colorectal Liver Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00072098
What this trial is testing

Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Max Sung 22
Not applicableStudy completedNCT01526200
What this trial is testing

Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases

Who this might be right for
Colon Cancer Liver Metastasis
University of Milan 127
Testing effectiveness (Phase 2)Ended earlyNCT02859415
What this trial is testing

Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases

Who this might be right for
Esophageal NeoplasmsLung NeoplasmsMesothelioma+2 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Looking for participantsNCT04701476
What this trial is testing

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

Who this might be right for
Colorectal Cancer; Lung Cancer
Teclison Ltd. 110
Testing effectiveness (Phase 2)UnknownNCT00997685
What this trial is testing

Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

Who this might be right for
Potentially Resectable Liver Metastasis From CRCColorectal Cancer
Guangdong Provincial People's Hospital 110
Not applicableStudy completedNCT00724503
What this trial is testing

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaLiver Metastases
Sirtex Medical 530
Early research (Phase 1)Study completedNCT00094003
What this trial is testing

Study of NS-9 in Patients With Liver Metastases

Who this might be right for
Liver NeoplasmsNeoplasm MetastasisLocal Neoplasm Recurrences
NS Pharma, Inc. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06590259
What this trial is testing

A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLM

Who this might be right for
Colorectal Cancer Liver Metastasis
Shanghai 6th People's Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02350530
What this trial is testing

FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 138
Large-scale testing (Phase 3)Active Not RecruitingNCT03428477
What this trial is testing

EPA for Metastasis Trial 2

Who this might be right for
Liver MetastasisColon Cancer
Mark A Hull, PhD FRCP 418
Testing effectiveness (Phase 2)Study completedNCT02316028
What this trial is testing

Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC)

Who this might be right for
Liver MetastasisColorectal Cancer
Universitair Ziekenhuis Brussel 11
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Early research (Phase 1)Ended earlyNCT04234113
What this trial is testing

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Thyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more
SOTIO Biotech AG 115
Not applicableUnknownNCT01815879
What this trial is testing

Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation Project

Who this might be right for
Colorectal CancerLiver Metastases
Andrew Kennedy 1,000
Not applicableLooking for participantsNCT07365527
What this trial is testing

Sonoporation and Tumor Microenvironment Response in Colorectal Liver Metastases

Who this might be right for
Liver Metastases From Colorectal Cancer
Zealand University Hospital 48
Testing effectiveness (Phase 2)Study completedNCT02082782
What this trial is testing

Efficacy of Irreversible Electroporation (IRE) for Central Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases
Amsterdam UMC, location VUmc 51
Testing effectiveness (Phase 2)Ended earlyNCT03844750
What this trial is testing

Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8+2 more
Chloe Atreya, MD, PhD 6
Testing effectiveness (Phase 2)UnknownNCT04189055
What this trial is testing

Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases.

Who this might be right for
Cancer Colorectal
Hôpital Franco-Britannique-Fondation Cognacq-Jay 72
Not applicableNot Yet RecruitingNCT07406126
What this trial is testing

Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases
Fernando Gómez Muñoz 30
Not applicableStudy completedNCT02781935
What this trial is testing

Diffusion-Weighted MRI for Liver Metastasis

Who this might be right for
Colorectal CancerColon Cancer Liver MetastasisMalignant Neoplasm of Rectum Metastatic to Liver
European Organisation for Research and Treatment of Cancer - EORTC 233
Next Page